Health Care & Life Sciences » Biotechnology | Omni Bio Pharmaceutical Inc.

Omni Bio Pharmaceutical Inc. | Balance Sheet

Fiscal year is April-March. All values USD Thousands.
2010
2011
2012
2013
2014
Cash & Short Term Investments
1,802.40
301.80
133.10
343.30
271.40
Other Current Assets
10.00
43.50
31.60
41.70
32.20
Total Current Assets
1,812.40
345.30
164.80
385.00
303.60
Net Property, Plant & Equipment
0.80
-
-
-
-
Total Investments and Advances
-
-
1,378.50
-
-
Intangible Assets
67.10
61.90
41.40
68.40
63.50
Other Assets
-
-
-
245.70
129.90
Total Assets
1,880.40
407.20
1,584.60
699.10
497.00
ST Debt & Current Portion LT Debt
26.10
-
-
-
-
Accounts Payable
94.40
41.80
88.70
42.50
8.70
Other Current Liabilities
97.50
165.00
189.20
81.00
87.60
Total Current Liabilities
218.00
206.70
277.90
123.50
96.30
Long-Term Debt
-
-
-
784.60
1,023.70
Other Liabilities
-
-
-
395.60
261.20
Total Liabilities
218.00
206.70
277.90
1,303.70
1,381.20
Common Equity (Total)
1,662.40
200.50
1,306.70
604.70
884.30
Total Shareholders' Equity
1,662.40
200.50
1,306.70
604.70
884.30
Total Equity
1,662.40
200.50
1,306.70
604.70
884.30
Liabilities & Shareholders' Equity
1,880.40
407.20
1,584.60
699.10
497.00

About Omni Bio Pharmaceutical

View Profile
Address
181 West Boardwalk Drive
Fort Collins Colorado 80525
United States
Employees -
Website http://www.omnibiopharma.com
Updated 07/08/2019
Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company, which engaes in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naurally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO.